Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Exclusion Criteria

• •1. Subjects administered any high energy (\>300 KeV) gamma-emitting radioisotope within five physical half-lives, or any IV iodinated contrast medium within 24 hours, or any high density oral contrast medium (oral water contrast is acceptable) within 5 days, prior to study drug injection.
• •2. Subjects with any medical condition or other circumstance that, in the opinion of the investigator, compromise obtaining reliable data, achieving study objectives, or completion.
• •Cohort A Only:
• •Patients with prior androgen deprivation therapy or any investigational neoadjuvant agent or intervention
• •Cohort B Only: \[Enrollment is Complete; No longer recruiting subjects\]
• •Prior radiation or ablative therapy to intended site of biopsy, if within the prostate bed
• •Initiation of new therapy for recurrent and/or progressive metastatic disease since radiographic documentation of recurrence/progression.